Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia  | Date: 2021-10-19

Kedrion Biopharma expands to North America with Prometic acquisition
  • Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency.
  • This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease.

Kedrion Biopharma Inc. has reportedly acquired Canada-based biopharmaceutical company Liminal BioSciences Inc. previously known as Prometic Life Sciences, as a part of the plans to expand its reach in North America.

The company is also working towards a launch in the United States in 2022, cited sources with reliable information.

For the record, Liminal BioSciences Inc. employs 130 people in Quebec and has developed the first FDA-certified treatment option for Congenital Plasminogen Deficiency. The new drug, named Ryplazim, can be used to treat Plasminogen Deficiency which can cause respiratory failure, blindness, and other chronic complications.

Chairperson of Kedrion Biopharma, Paolo Marcucci was quoted saying that the acquisition will ensure that patients suffering from this rare disease have easy access to treatment. He also claimed that the deal is a part of the company’s strategy to expand its reach in North America – a region from which the company derives nearly 50% of its revenues.

With the acquisition, Kedrion Biopharma has completed a series of transactions which the company started in June 2020, including the purchase of Liminal’s plasma purification plant at Laval in Quebec, and the license to distribute Ryplazim in the United States.

Chief Executive Officer of Kedrion Biopharma, Val Romberg reportedly said that the development & distribution of Ryplazim allows the company to fulfill the mission of putting patients first. This is the first FDA-approved drug for Type 1 Congenital Plasminogen Deficiency, and the company is honored to help speed its distribution in the market, he added.

In addition to the Quebec plant, Kedrion Biopharma also acquired two new plasma collection centers located in Winnipeg, Manitoba, and Amherst, New York as a part of this agreement.

Source Credits—

https://www.prnewswire.com/news-releases/kedrion-biopharama-grows-in-north-america-as-it-completes-acquisition-of-prometic-301401799.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

Pacific Island pushes Japan to delay wastewater release from Fukushima

Pacific Island pushes Japan to delay wastewater release from Fukushima

By Nikita Chaurasia

Pacific Island nations have reportedly pushed Japan to postpone the release of Fukushima nuclear power plant wastewater due to concerns that it may pollute fishing grounds. An appeal was made on Wednesday when Japan announced that treated sewage f...

Activist groups take Danone to court over excessive use of plastics

Activist groups take Danone to court over excessive use of plastics

By Nikita Chaurasia

Danone, the French bottled water and yogurt firm, is reportedly being sued in court by three environmental activists’ groups for failing to cut its plastic footprint significantly. According to the groups, the maker of Evian and Volvic miner...

Bosch expands security with dashcams designed for rideshare drivers

Bosch expands security with dashcams designed for rideshare drivers

By Nikita Chaurasia

Bosch, the German technology company, has reportedly expanded its security footprint in the ridesharing market with the launch of its latest security dashcams. At CES 2023, Las Vegas, the German tech firm unveiled a new integrated smart camera on ...

Australia: PM Albanese denies potential $450M payout to Rio Tinto

Australia: PM Albanese denies potential $450M payout to Rio Tinto

By Nikita Chaurasia

Australia's Prime Minister Anthony Albanese has reportedly denied rumors that Rio Tinto and its partners could receive a $450 million settlement for the Gladstone power station, which would bring the total compensation for the coal price limit to...

UK: Firms still struggle with post-Brexit trading and red tape

UK: Firms still struggle with post-Brexit trading and red tape

By Nikita Chaurasia

Businesses in the UK are still reportedly grappling after two years following the beginning of post-Brexit trading, as suggested by a new report. According to the British Chambers of Commerce (BCC), firms are still battling increased red tape and ...